Williams-Sonoma Total Cost of Revenue increased by 23.4% to $1.25B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 3.4%, from $1.30B to $1.25B. Over 2 years (FY 2023 to FY 2025), Total Cost of Revenue shows relatively stable performance with a -2.8% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.11B | $1.11B | $1.11B | $1.11B | $865.18M | $984.37M | $983.10M | $1.30B | $964.30M | $972.14M | $1.02B | $1.25B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -22.2% | +13.8% | -0.1% | +31.9% | -25.6% | +0.8% | +4.4% | +23.4% |
| YoY Change | — | — | — | — | -22.2% | -11.5% | -11.6% | +16.6% | +11.5% | -1.2% | +3.3% | -3.4% |